Who
Avraham Ben-Tzvi
Director
Company insider
Files Form 4 as: Director, Quantum Cyber; Director, Indaptus Therapeutics; Director, Titan Pharmaceuticals; Director, Bio Green Med Solution; Director, FiEE; Director, Opgen.
In numbers
- Trades disclosed
- 21
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 29 Jun 2023
- Last trade
- 31 Jul 2026
- Last filed
- 6 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 5 Aug 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code A | —112,259 at $0.00 | filing |
| 31 Jul 2026filed 5 Aug 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code A | —112,259 at $0.00 | filing |
| 22 Jul 2026filed 6 Aug 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code A | —112,859 at $0.00 | filing |
| 22 Jul 2026filed 6 Aug 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code A | —112,859 at $0.00 | filing |
| 8 May 2026filed 26 May 2026 | Mainz BiomedBiotechnology | SEC FORM 4 Code A | —137,141 at $0.00 | filing |
| 8 May 2026filed 26 May 2026 | QUCY Quantum CyberBiotechnology | SEC FORM 4 Code A | —137,141 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | INDP Indaptus TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | INDP Indaptus TherapeuticsBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 23 Dec 2025filed 22 Jan 2026 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 23 Dec 2025filed 22 Jan 2026 | INDP Indaptus Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Oct 2025filed 8 Oct 2025 | Titan Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —1,250 | filing |
| 1 Oct 2025filed 8 Oct 2025 | Titan Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —5,000 | filing |
| 1 Oct 2025filed 8 Oct 2025 | Titan Pharmaceuticals | SEC FORM 4 Code D | —3,313 | filing |
| 26 Feb 2025filed 28 Feb 2025 | BGMS Bio Green Med Solutionoption or derivative · Distributors & Wholesale | SEC FORM 4 Code A | —700,000 at $0.00 | filing |
| 26 Sep 2024filed 1 Oct 2024 | FIEE FiEESoftware | SEC FORM 4 Code A | —159,364 | filing |
| 11 Apr 2024filed 15 Apr 2024 | Opgen | SEC FORM 4 Code A | —100,000 | filing |
| 22 Jan 2024filed 24 Jan 2024 | FIEE FiEESoftware | SEC FORM 4 Code A | —25,000 | filing |
| 25 Oct 2023filed 26 Oct 2023 | Titan Pharmaceuticals | SEC FORM 4 Code A | —16,250 at $0.00 | filing |
| 26 Jul 2023filed 31 Jul 2023 | Titan Pharmaceuticals | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 29 Jun 2023filed 31 Jul 2023 | Titan Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.